Skip to main content

Medulloblastoma Initiation and Growth: Role of Hepatocyte Growth Factor

  • Chapter
  • First Online:
Pediatric Cancer, Volume 3

Part of the book series: Pediatric Cancer ((PECA,volume 3))

  • 1083 Accesses

Abstract

Hepatocyte growth factor/scatter factor (HGF/SF) is a polypeptide growth factor that drives cell cycle progression, blocks apoptosis, stimulates cell motility, and promotes angiogenesis in many tissues, especially during embryonic development. These diverse physiologic effects of HGF/SF are all mediated by a single cell surface receptor, the transmembrane tyrosine kinase encoded by the proto-oncogene c-Met. When pathologically overdriven, HGF/SF:c-Met signaling promotes tumor initiation and growth in many human cancers, including medulloblastoma, a pediatric brain tumor that originates from neural stem cells in the cerebellum. HGF/SF:c-Met signaling has emerged as a promising target for medulloblastoma therapy because the pathway is actively firing in tumor cells and because HGF/SF stimulates multiple oncogenic signaling molecules, against which specific molecular inhibitors have been designed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abounader R, Laterra J (2005) Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro Oncol 7:436–451

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Binning MJ, Niazi T, Pedone CA, Lal B, Eberhart CG, Kim KJ, Laterra J, Fults DW (2008) Hepatocyte growth factor and sonic hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Cancer Res 68:7838–7845

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915–925

    Article  CAS  PubMed  Google Scholar 

  • Coon V, Laukert T, Pedone CA, Laterra J, Kim KJ, Fults DW (2010) Molecular therapy targeting Sonic hedghoe and hepatocyte growth factor signaling in a mouse model of medulloblastoma. Mol Cancer Ther 9:2627–2636

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Crawford JR, MacDonald TJ, Packer RJ (2007) Medullo­blastoma in childhood: new biological advances. Lancet Neurol 6:1073–1085

    Article  CAS  PubMed  Google Scholar 

  • Fan S, Ma YX, Gao M, Yuan RQ, Meng Q, Goldberg ID, Rosen EM (2001) The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair. Mol Cell Biol 21:4968–4984

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Fogarty MP, Kessler JD, Wechsler-Reya RJ (2005) Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J Neurobiol 64:458–475

    Article  CAS  PubMed  Google Scholar 

  • Goodrich LV, Scott MP (1998) Hedgehog and patched in neural development and disease. Neuron 21:1243–1257

    Article  CAS  PubMed  Google Scholar 

  • Hallahan AR, Pritchard JI, Hansen S, Benson M, Stoeck J, Hatton BA, Russell TL, Ellenbogen RG, Bernstein ID, Beachy PA, Olson JM (2004) The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 64:7794–7800

    Article  CAS  PubMed  Google Scholar 

  • Hossain MA, Russell JC, Gomez R, Laterra J (2002) Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/akt-dependent and MAPK/CREB-independent. J Neurochem 81:365–378

    Article  CAS  PubMed  Google Scholar 

  • Ieraci A, Forni PE, Ponzetto C (2002) Viable hypomorphic signaling mutant of the Met receptor reveals a role for hepatocyte growth factor in postnatal cerebellar development. Proc Natl Acad Sci U S A 99:15200–15205

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jeffers M, Fiscella M, Webb CP, Anver M, Koochekpour S, Vande Woude GF (1998) The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci U S A 95:14417–14422

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J (2006) Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clin Cancer Res 12:1292–1298

    Article  CAS  PubMed  Google Scholar 

  • Kongkham PN, Northcott PA, Ra YS, Nakahara Y, Mainprize TG, Croul SE, Smith CA, Taylor MD, Rutka JT (2008) An epigenetic genome-wide screen identifies SPINT2 as a novel tumor suppressor gene in pediatric medulloblastoma. Cancer Res 68:9945–9953

    Article  CAS  PubMed  Google Scholar 

  • Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J, Mrsic A, Ylstra B, Grajkowska W, Hartmann W, Pietsch T, Ellison D, Clifford SC, Versteeg R (2008) Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3:e3088

    Article  PubMed Central  PubMed  Google Scholar 

  • Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R (2005) The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Cancer Res 65:9355–9362

    Article  CAS  PubMed  Google Scholar 

  • Li Y, Guessous F, Johnson EB, Eberhart CG, Li XN, Shu Q, Fan S, Lal B, Laterra J, Schiff D, Abounader R (2008) Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma. Lab Invest 88:98–111

    Article  CAS  PubMed  Google Scholar 

  • Liang TJ, Reid AE, Xavier R, Cardiff RD, Wang TC (1996) Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors. J Clin Invest 97:2872–2877

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N (1993) Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 268:10024–10028

    CAS  PubMed  Google Scholar 

  • Northcott PA, Fernandez LA, Hagan JP, Ellison DW, Grajkowska W, Gillespie Y, Grundy R, Van Meter T, Rutka JT, Croce CM, Kenney AM, Taylor MD (2009) The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 69:3249–3255

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Potempa S, Ridley AJ (1998) Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell 9:2185–2200

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Rao G, Pedone CA, Coffin CM, Holland EC, Fults DW (2003) c-Myc enhances Sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice. Neoplasia 5:198–204

    CAS  PubMed Central  PubMed  Google Scholar 

  • Romer JT, Kimura H, Magdaleno S, Sasai K, Fuller C, Baines H, Connelly M, Stewart CF, Gould S, Rubin LL, Curran T (2004) Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/−) p53(−/−) mice. Cancer Cell 6:229–240

    Article  CAS  PubMed  Google Scholar 

  • Sanchez P, Ruiz i Altaba A (2005) In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice. Mech Dev 122:223–230

    Article  CAS  PubMed  Google Scholar 

  • Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G (1997) Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A 94:701–706

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Thompson MC, Fuller C, Hogg TL, Dalton J, Finkelstein D, Lau CC, Chintagumpala M, Adesina A, Ashley DM, Kellie SJ, Taylor MD, Curran T, Gajjar A, Gilbertson RJ (2006) Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol 24:1924–1931

    Article  CAS  PubMed  Google Scholar 

  • Toschi L, Jänne PA (2008) Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin Cancer Res 14:5941–5946

    Article  CAS  PubMed  Google Scholar 

  • Wang R, Ferrell LD, Faouzi S, Maher JJ, Bishop JM (2001) Activation of the Met receptor by cell attachment induces and sustains hepatocellular carcinomas in transgenic mice. J Cell Biol 153:1023–1034

    Article  CAS  PubMed  Google Scholar 

  • Weiner HL, Bakst R, Hurlbert MS, Ruggiero J, Ahn E, Lee WS, Stephen D, Zagzag D, Joyner AL, Turnbull DH (2002) Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1. Cancer Res 62:6385–6389

    CAS  PubMed  Google Scholar 

  • Xiao GH, Jeffers M, Bellacosa A, Mitsuuchi Y, Vande Woude GF, Testa JR (2001) Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylino­sitol 3-kinase/Akt and mitogen-activated protein kinase pathways. Proc Natl Acad Sci U S A 98:247–252

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel W. Fults .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Fults, D.W. (2012). Medulloblastoma Initiation and Growth: Role of Hepatocyte Growth Factor. In: Hayat, M. (eds) Pediatric Cancer, Volume 3. Pediatric Cancer, vol 3. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-4528-5_11

Download citation

Publish with us

Policies and ethics